SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: belisarius who wrote (7896)10/19/2009 4:28:38 PM
From: idahoranch1  Read Replies (2) of 63327
 
It IS just an abstract, but it doesn't impress me, not to the tune of it taking HGSI to a $3 billion market cap.

It doesn't appear to beat the placebo significantly in any area. It's side effects are a little more severe in most cases. The end point where they lower the steroids is a joke, they can take away the steriod at week 52 and get a brownie point for it??? I guess it doesn't matter if they have to raise it again in a month or two? I mean, there is no way to know if that lowered use is real.

Maybe there is data behind all this that is a lot better than this.

I don't know how significant a 4 point reduction in the SELENA-SLEDAI is, do you know what percentage that would be Li?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News